Related News
US officials defend swine flu vaccination plan
Source: Agencies |
November 18, 2009, Wednesday
|
Online Edition
Online Edition
US public health officials defended the distribution of swine flu vaccines yesterday against criticism that their plan to protect Americans was confusing and over-optimistic.
Manufacturers have delivered 48.5 million doses of H1N1 vaccine, Dr. Anne Schuchat of the US Centers for Disease Control and Prevention told a Senate hearing. HHS had hoped to have as many as 120 million doses by now.
The problem was worsened because the first vaccine to be available was a nasal spray made by AstraZeneca unit MedImmune that is not suitable for some of the most vulnerable groups but which is perfect for most schoolchildren and healthcare workers, officials said.
Members of the Senate Homeland Security and Governmental Affairs Committee pressed for an apology and said they felt President Barack Obama's administration had not learned some valuable lessons from the continuing problem.
"I am worried that we are undermining confidence in our public health system," said committee chairman, Connecticut independent Sen. Joseph Lieberman.
He said he feared people who have waited in vain to be vaccinated against H1N1 swine flu will stop trying.
"This hearing is critical to peeling away the layers of misinformation and miscommunication that has hampered the federal government's pandemic influenza strategy," added Maine Republican Senator Susan Collins.
The US government is struggling to vaccinate as many people as possible against the virus, which has infected an estimated 22 million Americans and killed 3,900.
In September HHS Secretary Kathleen Sebelius had assured Congress, "There will be enough vaccines for everyone."
"I think we led expectations of availability to be higher than they have been. I think that led to frustration," Schuchat said.
ADMITTING MISTAKES
"I think you used the word mistake and it is important to acknowledge that here," Lieberman said.
HHS spokeswoman Jenny Backus later said Sebelius's promise was not a mistake.
"The problem has been that lots of people want it all at the same time and that has been a challenge and we understand that people are frustrated," Backus said by email.
"Vaccine came off the production lines slower than what the original predictions were and we made the tough choice to start the vaccination program as soon as vaccine was ready to go even though we knew that supplies would be low."
The vaccination plan was chosen at a July meeting of the Advisory Committee on Immunization Practices, an independent group of experts that advises the CDC on vaccine policies.
They agreed to create five broad priority groups totaling 159 million people -- pregnant women, healthcare workers, people with asthma or other conditions that put them at high risk of flu complications, caregivers of infants too young to be vaccinated, and children and adults aged up to 24.
Lieberman said he thought HHS and CDC should have revised the priority groups downward to the 42 million people deemed most in need of vaccination, but Schuchat said the committee met again in October and decided not to modify its recommendations.
"What we heard pretty consistently was leave the flexibility to the state and locals. Let them decide," she said. Many wanted to run school-based clinics and narrowing the designated priority groups would have meant the most available vaccine -- the spray -- could not be broadly used.
Manufacturers have delivered 48.5 million doses of H1N1 vaccine, Dr. Anne Schuchat of the US Centers for Disease Control and Prevention told a Senate hearing. HHS had hoped to have as many as 120 million doses by now.
The problem was worsened because the first vaccine to be available was a nasal spray made by AstraZeneca unit MedImmune that is not suitable for some of the most vulnerable groups but which is perfect for most schoolchildren and healthcare workers, officials said.
Members of the Senate Homeland Security and Governmental Affairs Committee pressed for an apology and said they felt President Barack Obama's administration had not learned some valuable lessons from the continuing problem.
"I am worried that we are undermining confidence in our public health system," said committee chairman, Connecticut independent Sen. Joseph Lieberman.
He said he feared people who have waited in vain to be vaccinated against H1N1 swine flu will stop trying.
"This hearing is critical to peeling away the layers of misinformation and miscommunication that has hampered the federal government's pandemic influenza strategy," added Maine Republican Senator Susan Collins.
The US government is struggling to vaccinate as many people as possible against the virus, which has infected an estimated 22 million Americans and killed 3,900.
In September HHS Secretary Kathleen Sebelius had assured Congress, "There will be enough vaccines for everyone."
"I think we led expectations of availability to be higher than they have been. I think that led to frustration," Schuchat said.
ADMITTING MISTAKES
"I think you used the word mistake and it is important to acknowledge that here," Lieberman said.
HHS spokeswoman Jenny Backus later said Sebelius's promise was not a mistake.
"The problem has been that lots of people want it all at the same time and that has been a challenge and we understand that people are frustrated," Backus said by email.
"Vaccine came off the production lines slower than what the original predictions were and we made the tough choice to start the vaccination program as soon as vaccine was ready to go even though we knew that supplies would be low."
The vaccination plan was chosen at a July meeting of the Advisory Committee on Immunization Practices, an independent group of experts that advises the CDC on vaccine policies.
They agreed to create five broad priority groups totaling 159 million people -- pregnant women, healthcare workers, people with asthma or other conditions that put them at high risk of flu complications, caregivers of infants too young to be vaccinated, and children and adults aged up to 24.
Lieberman said he thought HHS and CDC should have revised the priority groups downward to the 42 million people deemed most in need of vaccination, but Schuchat said the committee met again in October and decided not to modify its recommendations.
"What we heard pretty consistently was leave the flexibility to the state and locals. Let them decide," she said. Many wanted to run school-based clinics and narrowing the designated priority groups would have meant the most available vaccine -- the spray -- could not be broadly used.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
